Long-Term Persistence and Effectiveness of Risankizumab in Multi-Refractory Psoriatic Arthritis: A 16-Center Real-World Registry (SKYREAL) (ACR Convergence 2026) - Sep 8, 2026 - Abstract #363; Pres time: Nov 8, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Immunology • Inflammatory Arthritis • Psoriatic Arthritis • Rheumatology • Seronegative Spondyloarthropathies
|
|
Maria Vanesa Hernandez Hernandez, MD
|